Guest Editors
Dr. Shu-Yu Wu
Email: nobookrain2014@gmail.com
Affiliation: Department of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan
Homepage:
Research Interests: urolithiasis, urinary tract infection, endourology
Dr. Chun-Kai Hsu
Email: svevi0614@gmail.com
Affiliation: Department of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan
Homepage:
Research Interests: urolithiasis, urinary tract infection, endourology
Summary
Urolithiasis is a common and recurrent condition affecting millions worldwide, often associated with significant morbidity and healthcare burden. Its pathogenesis involves a complex interplay of metabolic disturbances, genetic predisposition, and environmental influences. In recent years, growing attention has been directed toward the association between urinary stone disease and urinary tract infections (UTIs), along with the roles of systemic inflammation, alterations in the urinary microbiome, and metabolic syndrome. As surgical techniques continue to advance, so too does the recognition that successful management of urolithiasis requires more than procedural expertiseit necessitates a comprehensive, patient-centered approach.
This special issue aims to provide a focused platform for high-quality research and reviews that reflect the multifaceted nature of urolithiasis. It will explore contemporary trends in diagnosis and management while integrating perspectives on infectious complications, metabolic risk factors, and innovations in both surgical and medical therapies. Our goal is to bridge the gap between clinical practice and emerging research, offering insights that are valuable to urologists, nephrologists, and translational scientists alike.
We welcome original research articles, systematic reviews, clinical studies, and expert commentaries that address the diagnosis, prevention, pathophysiology, and multidisciplinary management of urolithiasis in both adult and pediatric populations.
Suggested Themes
·Infection-related stones and urinary microbiome
·Metabolic evaluation and personalized prevention strategies
·Endourological innovations: RIRS, PCNL, URS
·Non-invasive therapies and recurrence prevention
·Pediatric and high-risk population considerations
·Surgical complications and quality-of-life outcomes
·AI and biomarkers in stone risk prediction
Keywords
urolithiasis, urinary tract infection (UTI), metabolic syndrome, endourology, urinary microbiome, minimally invasive urologic surgery, multidisciplinary urolithiasis management
Login
Register
Submit a Paper
Propose a Special lssue